Most importantly, while MYC overexpression induced resistance to BRAF inhibitors in melanoma cells in vitro, it also sensitized the cells to inhibitors of glucose metabolism, glutaminolysis and other metabolic processes, pointing to actionable MYC‐induced metabolic dependencies [114]. The gene discussed is BRAF; the disease is melanoma.